Skip to main content
Toggle navigation
Login
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Radice, Casey
Merck
PII-104
-
CLINICAL TRIAL SIMULATIONS FOR OPTIMAL SAMPLING TO ASSESS DURABILITY OF PCV IMMUNE RESPONSE IN ADULTS.
Casey Radice
Favorite
Radwan, Alaa
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado|Anschutz Medical Campus
OAII-001
-
EVALUATION OF PHARMACOGENOMIC MEDICATION PRESCRIBING PATTERNS IN RURAL VERSUS URBAN SETTINGS.
Alaa Radwan
Favorite
PII-076
-
ESTIMATED PREVALENCE OF ACTIONABLE EXPOSURES TO PHARMACOGENETIC SUPPORTIVE CARE MEDICATIONS AMONG PATIENTS WITH GASTROINTESTINAL CANCERS.
Alaa Radwan
Favorite
PT-004
-
EVALUATION OF PHARMACOGENOMIC MEDICATION PRESCRIBING PATTERNS IN RURAL VERSUS URBAN SETTINGS.
Alaa Radwan
Favorite
Ramesh, Shyam
University of Florida
PII-099
-
AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE: JOINT LONGITUDINAL-SURVIVAL DISEASE PROGRESSION MODELS.
Shyam Ramesh
Favorite
RATH, SEEPRARANI
Rutgers, the State University of New Jersey
PT-026
-
CAN MODEL BASED APPROACHES ACCURATELY IDENTIFY BIO(IN)EQUIVALENCE OF TOPICAL CLOTRIMAZOLE PRODUCTS?
SEEPRARANI RATH
Favorite
Raviele, Anthony
Bristol Myers Squibb
PII-021
-
EXPOSURE RESPONSE (E-R) RELATIONSHIPS OF LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL)
Anthony Raviele
Favorite
Remaily, Bryan
The Ohio State University
PII-011
-
FC GAMMA RECEPTORS CONTRIBUTE TO CACHEXIA MEDIATED INCREASES IN MONOCLONAL ANTIBODY CLEARANCE
Bryan Remaily
Favorite
PT-018
-
MINIMAL SAMPLING TO ASSESS MECHANISMS LINKING IMMUNE CHECKPOINT INHIBITOR PHARMACOKINETICS AND OUTCOMES IN CANCER PATIENTS
Bryan Remaily
Favorite
PWII-003
-
MINIMAL SAMPLING TO ASSESS MECHANISMS LINKING IMMUNE CHECKPOINT INHIBITOR PHARMACOKINETICS AND OUTCOMES IN CANCER PATIENTS
Bryan Remaily
Favorite
Riselli, Andrew
University of California, San Francisco
TIP-001
-
A CLINICAL STUDY OF NOVEL BCRP AND ESTABLISHED OATP BIOMARKERS FOR PREDICTING DRUG-DRUG INTERACTIONS.
Andrew Riselli
Favorite
Ryu, Kyongkuk
Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University
LB-031
-
POPULATION PHARMACOKINETICS OF BORTEZOMIB: MODEL-BASED META-ANALYSIS
Kyongkuk Ryu
Favorite
